Perioperative Immunotherapy and ctDNA-Based MRD Testing

Abstract

Get full access to this article

View all access options for this article.

References

Hadd

, Silvestro

, McKelvey

, et al. Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium. Clin Transl Sci. , 2025 Mar; 18(3):e70185. doi: 10.1111/cts.70185

Suraya

, Nagano

, Tachihara

. Recent Advances in Mesothelioma Treatment: Immunotherapy, Advanced Cell Therapy, and Other Innovative Therapeutic Modalities. Cancers (Basel) . 2025; 17(4):694. Published 2025 Feb 18. doi:10.3390/cancers17040694

Reuss

, Lee

, Mehran

, et al. Perioperative nivolumab or nivolumab plus ipilimumab in resectable diffuse pleural mesothelioma: a phase 2 trial and ctDNA analyses. Nat Med. , 2025. doi:10.1038/s41591-025-03958-3